Zhejiang Hengtong Hits Day High with Strong 3.43% Intraday Surge

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 3.43% on June 5, 2026. The stock reached an intraday high of CNY 7.15, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index declined by 0.74% on the same day. Over the past week, Zhejiang Hengtong has demonstrated an impressive 8.61% increase, and its one-month performance stands at 28.52%. The stock has also outperformed the market significantly over the past year, with a remarkable 150.54% gain, compared to the China Shanghai Composite's 19.02%. Year-to-date, the stock has risen by 30.21%, further highlighting its robust performance. Despite these positive short-term trends, the company faces challenges with a high debt-equity ratio of 8.99% and rising raw material costs, which have increased by 32.65% year-over-year. Nevertheless, with a market capitalization of CNY 17,570 million and a price-to-book ratio of 4.74, Zhejiang Hengtong continues to be a notable entity in its industry.